Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07064291 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enhancing Self-Esteem in Patients With Multiple Sclerosis: A Randomised Controlled Trial of the Lexical Association Technique

Study acronym: SE-P-MS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 8 more changesShow less
    • Start date changed from estimate of Sep 2025 to Jan 28, 2026
    • Primary endpoints: details revised at 1 of 1 entry
    • Primary and study completion moved earlier from Sep 2027 to Jul 27, 2027
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 7 of 7 entries
    • Study description revised
    • Site details revised
    • Publications: details revised at 23 of 25 entries
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn whether the Lexical Association Technique (LAT) can improve well-being in people recently diagnosed with multiple sclerosis (MS), either relapsing-remitting (RRMS) or secondary progressive (SPMS). The main questions it aims to answer are: * Does the LAT increase well-being more than a placebo technique ? * Does this technique help reduce psychological distress and improve quality of life ? Participants will: * Be randomly assigned to either the LAT group or the active control group * Complete short visualization exercises at home using a personal computer * Fill out questionnaires about self-esteem, stress, anxiety, depression, quality of life, and adjustment to illness * Take part in the study over several weeks, with assessments before, after, and 14 days after the intervention Researchers will compare results between the two groups (LAT group vs. Control group) to test the immediate and lasting effects of the LAT.
Trial Details
NCT Number NCT07064291
Lead Sponsor University Hospital, Grenoble
Collaborators: Laboratoire interuniversitaire de psychologie : personnalité, cognition et changement social - LIP-PC2S, Laboratoire de Psychologie et NeuroCognition
Conditions
(from sponsor)
Multiple Sclerosis, Quality of Life (QOL)
Related terms Multiple Sclerosis, Psychological Well-Being
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov